Are you Dr. Xu?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 16 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
7301 College Blvd
Ste. 110
Overland Park, KS 66210Phone+1 913-341-6297Fax+1 913-341-6299- Is this information wrong?
Summary
- Dr. Xiao Xu, MD is a board certified pathologist in Overland Park, Kansas. She is currently licensed to practice medicine in Kansas, Arizona, and Texas. She is affiliated with Overland Park Regional Medical Center.
Education & Training
Rutgers Health/Robert Wood Johnson Medical SchoolResidency, Pathology-Anatomic and Clinical, 1995 - 1998
Shanghai Medical UniversityClass of 1987
Certifications & Licensure
AZ State Medical License 2019 - 2026
CA State Medical License 2017 - 2024
TX State Medical License 2019 - 2021
MO State Medical License 2010 - 2020
KS State Medical License 2009 - 2020- American Board of Pathology Anatomic Pathology & Clinical Pathology
Publications & Presentations
PubMed
- 6 citationsA prospective analysis of touch preparation cytology for intraoperative detection of mediastinal lymph node metastases.Alison Wenholz, Xiao Meng Xu, Ranjana Nawgiri, Ikenna C. Okereke> ;Journal of the American Society of Cytopathology. 2019 Mar 1
- 78 citationsEconomic cost of fecal incontinence.Xiao Xu, Stacy B. Menees, Melissa K. Zochowski, Dee E. Fenner> ;Diseases of the Colon and Rectum. 2012 May 1
- 22 citationsEndophthalmitis caused by Vibrio alginolyticus.Xiao Chun Li, Zhen Yang Xiang, Xiao Ming Xu, Wei Hua Yan, Jian Min Ma> ;Journal of Clinical Microbiology. 2009 Oct 1
- Join now to see all
Press Mentions
Effects of ATP9A on Extracellular Vesicle Release and Exosomal Lipid CompositionOctober 29th, 2020
Severity of Early Allograft Dysfunction Following Donation After Circulatory Death Liver Transplantation: A Multicentre StudyOctober 14th, 2019
ACEA Biosciences Announces Successful Completion of Phase I Clinical Study of Novel Autoimmune Disease DrugJune 14th, 2017
Hospital Affiliations
- Overland Park Regional Medical CenterLenexa, Kansas
